Company · founded 2007
Biomarker Strategies (United States)
Rockville, United States · biomarkerstrategies.com
- Citations, last 5 years
- 7
- Works, last 5 years
- 2
- h-index
- 9
- Scientists listed
- 1
- Grants since 2016
- 4
Grants received
2019–2021 · contract · N44
SBIR Topic 354: A Novel Predictive Test for Response to Combination Immunotherapies for Patients with non-small cell lung cancer (NSCLC)
Greg Bertenshaw · Biomarker Strategies (United States) · funded by National Institutes of Health
2017–2019 · research · R43
Development of a companion diagnostic to predict response to cetuximab in patients with head and neck squamous cell carcinoma
Greg Bertenshaw · Biomarker Strategies (United States) · funded by National Institutes of Health
2016–2017 · contract · N43
IGF::OT::IGF SBIR PHASE I TOPIC 354-A NOVEL PREDICTIVE TEST FOR RESPONSE TO IMMUNOTHERAPIES FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER; POP 09/19/16-06/18/17
Greg Bertenshaw · Biomarker Strategies (United States) · funded by National Institutes of Health
2015–2021 · research · R44
PathMAP NSCLC: A functional companion diagnostic test to predict optimal therapy for patients with non-small cell lung cancer.
Greg Bertenshaw · Biomarker Strategies (United States) · funded by National Institutes of Health
